Immune and tissue cell populations via paracrine and cell-contact mechanisms

The term 'Immune and tissue cell populations via paracrine and cell-contact mechanisms' does not refer to a single molecular target but rather describes the complex physiological interactions characteristic of cell-based therapies, particularly Mesenchymal Stem Cells (MSCs). These cells function by modulating the activity of various immune cells, such as T-cells and macrophages, and resident tissue cells through two primary pathways: the secretion of soluble bioactive factors (paracrine signaling) and direct physical binding (cell-contact mechanisms) (Galipeau & Sensébé, 2018). Paracrine factors include cytokines like IL-10 and growth factors that promote a pro-regenerative environment, while cell-contact interactions often involve inhibitory molecules like PD-L1 that dampen overactive immune responses (Wang et al., 2020). This multi-modal approach allows for broad therapeutic effects across diverse inflammatory and degenerative conditions, such as Graft-versus-Host Disease and Crohn's disease (Pittenger et al., 2019). Because it represents a high-level biological process involving numerous proteins and cell types, it is classified as a mechanism of action rather than a discrete pharmacological target. Consequently, drugs interacting with this 'target' are typically living cell products rather than small molecules or monoclonal antibodies.

Other names

Mesenchymal stem cell immunomodulationParacrine and cell-contact mediated signalingCellular crosstalkMSC-mediated paracrine signaling

Modulation of immune and tissue cell populations through the combined action of secreted soluble factors and direct cell-to-cell physical interactions.